{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:07:36Z","timestamp":1781741256402,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T00:00:00Z","timestamp":1306195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Negat Results BioMed"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1477-5751-10-6","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T18:18:53Z","timestamp":1306261133000},"source":"Crossref","is-referenced-by-count":9,"title":["No connection between the level of exposition to statins in the population and the incidence\/mortality of acute myocardial infarction: An ecological study based on Sweden's municipalities"],"prefix":"10.1186","volume":"10","author":[{"given":"Staffan","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigvard","family":"M\u00f6lstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Karlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Erik","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-G\u00f6ran","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,24]]},"reference":[{"key":"96_CR1","unstructured":"Myocardial infarctions in Sweden 1987-2008. The Swedish Board of Health and Welfare. \n                    http:\/\/www.socialstyrelsen.se\/publikationer2010\/2010-11-17"},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s002280050595","volume":"55","author":"J Merlo","year":"1999","unstructured":"Merlo J, Lindberg G, Lindblad U, Lindgren A, Rastam L, Melander A: Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalities. Eur J Clin Pharmacol. 1999, 55: 69-76. 10.1007\/s002280050595.","journal-title":"Eur J Clin Pharmacol"},{"key":"96_CR3","unstructured":"The AMI Statistics at The Swedish Board of Health and Welfare, Centre of Epidemiology. \n                    http:\/\/www.socialstyrelsen.se"},{"key":"96_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005, 366: 1267-1278.","journal-title":"Lancet"},{"key":"96_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(94)91755-8","volume":"344","author":"Pedersen","year":"1994","unstructured":"Pedersen: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994, 344: 1383-1389.","journal-title":"Lancet"},{"key":"96_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","volume":"333","author":"J Shepherd","year":"1995","unstructured":"Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995, 333: 1301-1307. 10.1056\/NEJM199511163332001.","journal-title":"N Engl J Med"},{"key":"96_CR7","unstructured":"WHO Colloborating Centre for Drug Statistics Methodology. \n                    http:\/\/www.whocc.no"},{"key":"96_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","volume":"36","author":"JS Alpert","year":"2000","unstructured":"Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000, 36: 959-969. 10.1016\/S0735-1097(00)00804-4.","journal-title":"J Am Coll Cardiol"},{"key":"96_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","volume":"356","author":"L Wallentin","year":"2000","unstructured":"Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000, 356: 9-16. 10.1016\/S0140-6736(00)02427-2.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"96_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1136\/jech.49.Suppl_2.S3","volume":"49","author":"V Carstairs","year":"1995","unstructured":"Carstairs V: Deprivation indices: their interpretation and use in relation to health. J Epidemiol Community Health. 1995, 49 (Suppl 2): S3-8. 10.1136\/jech.49.Suppl_2.S3.","journal-title":"J Epidemiol Community Health"},{"key":"96_CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/oxfordjournals.eurheartj.a059895","volume":"12","author":"C Nerbrand","year":"1991","unstructured":"Nerbrand C, Olsson L, Svardsudd K, Kullman S, Tibblin G: Are regional variations in ischaemic heart disease related to differences in coronary risk factors? The project 'myocardial infarction in mid-Sweden'. Eur Heart J. 1991, 12: 309-314.","journal-title":"Eur Heart J"},{"key":"96_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2796.1991.tb00478.x","volume":"230","author":"S Gyllerup","year":"1991","unstructured":"Gyllerup S, Lanke J, Lindholm LH, Schersten B: High coronary mortality in cold regions of Sweden. J Intern Med. 1991, 230: 479-485. 10.1111\/j.1365-2796.1991.tb00478.x.","journal-title":"J Intern Med"},{"key":"96_CR13","unstructured":"Sveriges Kommuner och Landsting. \n                    http:\/\/www.skl.se\/web\/Aldre_indelning_1999-2004.aspx"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/oxfordjournals.aje.a114892","volume":"127","author":"S Piantadosi","year":"1988","unstructured":"Piantadosi S, Byar DP, Green SB: The ecological fallacy. Am J Epidemiol. 1988, 127: 893-904.","journal-title":"Am J Epidemiol"},{"key":"96_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1365-2796.2000.00716.x","volume":"248","author":"M Rosen","year":"2000","unstructured":"Rosen M, Alfredsson L, Hammar N, Kahan T, Spetz CL, Ysberg AS: Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. Results from the national AMI register in Sweden. J Intern Med. 2000, 248: 159-164. 10.1046\/j.1365-2796.2000.00716.x.","journal-title":"J Intern Med"},{"key":"96_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.288.4.462","volume":"288","author":"CA Jackevicius","year":"2002","unstructured":"Jackevicius CA, Mamdani M, Tu JV: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Jama. 2002, 288: 462-467. 10.1001\/jama.288.4.462.","journal-title":"Jama"},{"key":"96_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ije\/dyg073","volume":"32","author":"I Andersen","year":"2003","unstructured":"Andersen I, Osler M, Petersen L, Gronbaek M, Prescott E: Income and risk of ischaemic heart disease in men and women in a Nordic welfare country. Int J Epidemiol. 2003, 32: 367-374. 10.1093\/ije\/dyg073.","journal-title":"Int J Epidemiol"},{"key":"96_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jech.2003.014563","volume":"58","author":"BH Strand","year":"2004","unstructured":"Strand BH, Tverdal A: Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50,000 Norwegian men and women. J Epidemiol Community Health. 2004, 58: 705-709. 10.1136\/jech.2003.014563.","journal-title":"J Epidemiol Community Health"},{"key":"96_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/bmj.38561.633345.8F","volume":"331","author":"B Unal","year":"2005","unstructured":"Unal B, Critchley JA, Capewell S: Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. Bmj. 2005, 331: 614-10.1136\/bmj.38561.633345.8F.","journal-title":"Bmj"},{"key":"96_CR20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","volume":"328","author":"R Doll","year":"2004","unstructured":"Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years' observations on male British doctors. Bmj. 2004, 328: 1519-10.1136\/bmj.38142.554479.AE.","journal-title":"Bmj"},{"key":"96_CR21","doi-asserted-by":"crossref","unstructured":"Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM: Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 121: 1069-1077.","DOI":"10.1161\/CIRCULATIONAHA.109.906479"},{"key":"96_CR22","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1001\/jama.291.18.2243","volume":"291","author":"JM Walsh","year":"2004","unstructured":"Walsh JM, Pignone M: Drug treatment of hyperlipidemia in women. Jama. 2004, 291: 2243-2252. 10.1001\/jama.291.18.2243.","journal-title":"Jama"}],"container-title":["Journal of Negative Results in BioMedicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-5751-10-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-5751-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-5751-10-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-5751-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T01:08:14Z","timestamp":1548205694000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnrbm.biomedcentral.com\/articles\/10.1186\/1477-5751-10-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1186\/1477-5751-10-6","relation":{},"ISSN":["1477-5751"],"issn-type":[{"value":"1477-5751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,24]]},"article-number":"6"}}